abbvie glp-1 receptor agonist weight management diabetes treatments GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Is GLP-1 Safe for Weight

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

Consistency in measurement method matters more than absolute accuracy

Researchers with metabolic syndrome, elevated liver enzymes, or suspected NAFLD have a metabolic profile that aligns well with the dual benefits of tirzepatide (glycemic control, appetite reduction) and levocarnitine (enhanced hepatic fat oxidation, improved insulin sensitivity at the cellular level)

Chois group tried to use adipose tissue-derived MSCs (AD-MSCs) to treat OA

WD is caused by mutations in ATP7B , which encodes a transmembrane copper-transporting ATPase, leading to impaired copper homeostasis and copper overload in the liver, brain and other organs

Patel, brain issues or diseases are generally more difficult to reverse because theyve been there a long time